"10.1371_journal.pone.0053492","plos one","2012-12-31T00:00:00Z","Gene-Errol E Ringpis; Saki Shimizu; Hubert Arokium; Joanna Camba-Col√≥n; Maria V Carroll; Ruth Cortado; Yiming Xie; Patrick Y Kim; Anna Sahakyan; Emily L Lowe; Munetoshi Narukawa; Fadi N Kandarian; Bryan P Burke; Geoff P Symonds; Dong Sung An; Irvin S Y Chen; Masakazu Kamata","Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America; University of California Los Angeles AIDS Institute, Los Angeles, California, United States of America; Division of Hematology-Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America; Calimmune, Inc., Los Angeles, California, United States of America; University of California Los Angeles School of Nursing, Los Angeles, California, United States of America; Department of Biology, California State University Northridge, Northridge, California, United States of America; University of California Los Angeles Broad Stem Cell Research Center, Los Angeles, California, United States of America","Conceived and designed the experiments: GER SS HA BPB GPS DSA ISYC MK. Performed the experiments: GER SS HA JC MVC RC YX PK AS ELL MN FNK MK. Analyzed the data: GER SS HA JC MVC BPB MK. Wrote the paper: GER ISYC MK.","ISYC and DSA have a financial interest in Calimmune, Inc. Calimmune is a subcontractor of the grant from CIRM. GER, ISYC, and MK are co-inventors of a provisional application for patent titled SHRNA VECTORS FOR THE TREATMENT OF HIV, #US 61/647,201 (UCLA Case 2012-623-1). All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2012","12","Gene-Errol E Ringpis","GEER",17,FALSE,8,13,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
